You are currently viewing a beta version of our website. If you spot anything unusual, kindly let us know.
Altmetrics
Downloads
159
Views
48
Comments
0
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Peak No. | Rt (min) | [M+H]+ | [M―H]― | Err PPM | Molecular formula | Tentative Identification | Literature Review of the Compounds |
---|---|---|---|---|---|---|---|
Peak A (M1) | (21.445 ― 21.793) | 433.29 | 431.5 | ―0.65 | C21H20O10 | Apigenin-6-C-glucoside(isovitexin) | [23,24] |
Peak B (M2) | (36.628 ― 36.694) | 449.29 | 447.3 | ―0.50 | C21H20O11 | Luteolin-8-C-glucoside (orientin) | [23,24] |
Peak C (M3) | (32.948 ― 32.965) | 771.50 | 769.7 | ―0.45 | C37H38O18 | Isovitexin-7-O-glucoside | [23] |
Peak D (M4) | (31.058 ― 31.257) | 355.24 | 353.5 | ―0.65 | C16H18O9 | 5-Caffeoylquinic acid | [23] |
Peak E (M5) | (27.893 ― 28.125) | 273.2 | 271.3 | ―0.45 | C15H12O5 | Naringenin | [21,24–26] |
Peak F (M6) | (29.484 ― 29.650) | 305.14 | 303.3 | ―0.65 | C15H12O7 | Taxifolin | [26] |
Peak G (M7) | (25.754 ― 25.821) | 287.13 | 285.3 | ―0.40 | C15H12O6 | Luteolin | [21,26] |
Peak H (M8) | (28.804 ― 29.268) | 303.13 | 301.9 | ―0.70 | C15H10O7 | Quercetin | [23,25,26] |
Peak I (M9) | (32.020 ― 32.467) | 611.34 | 609.4 | ―0.65 | C27H30O16 | Rutin | [21,26] |
Peak J (M10) | (33.048 ― 33.765) | 373.46 | 371.37 | ―0.70 | C21H24O6 | Hierochin B | [21,26] |
Peak K (M11) | (26.142 ― 26.324) | 319.32 | 317.38 | ―0.85 | C17H18O6 | Evofolin B | [21] |
Peak L (M12) | (28.173 ― 28.397) | 357.46 | 355.39 | ―0.65 | C20H20O6 | Balanophonin | [21,26] |
Metabolite Name | Glide Docking Score | Molecular interactions |
---|---|---|
Apigenin-6-C-glucoside | -10.26 | H bonds: LEU 648 π-π : PHE 649, PHE 1013 |
Luteolin-8-C-glucoside | -8.40 | H bonds: GLU 802, LYS 771 π-π: PHE 649, PHE 1013 |
Isovitexin 7-O-[isoferuloyl]-glucoside | -4.49 | H bonds: THR 1010 π-π: PHE 649, LYS 771, PHE 914, PHE 1009, PHE 1013 |
Cis-5-caffeoylquinic acid | -10.19 | H bonds: LEU 648, THR 1010 π-π: PHE 914, PHE 1009 |
Naringenin | -9.96 | H bonds: GLU 802, THR 1010 π-π: PHE 914, PHE 1009 |
Taxifolin | -7.88 | H bonds: GLU 802 π-π: PHE 649, PHE 1013 |
Luteolin | -10.43 | H bonds: SER 876, ARG 880, THR 1010 π-π: PHE 914, PHE 1009 |
Quercetin | -11.15 | H bonds: GLU 802, SER 876, ARG 880, THR 1010 π-π: PHE 914, PHE 1009 |
Rutin | -12.39 | H bonds: GLU 802, GLU 879, SER 876, HIS 875 Pi-Pi: PHE 1013 π-cation: LYS 771 |
Hierochin B | -7.75 | π-π: PHE 1009 |
Evofolin B | -8.54 | H bonds: LYS771, SER 876 π-π: PHE 914, PHE 1009, PHE 1013 |
Balanophonin | -8.53 | H bonds: LYS 771 π-π: PHE 914, PHE 1009 |
Metabolite | Rutin | Quercetin | Luteolin | Allopurinol |
IC50 value (µM) | 11.35 ±2.09 | 11.1 ±1.72 | 21.58 ±2.41 | 4.3±1.01 |
Properties | Parameters | Apigenin-6-C-glucoside | Luteolin-8-C-glucoside | Isovitexin 7-O-[isoferuloyl]-glucoside | Cis-5-caffeoylquinic acid | Naringenin | Taxifolin | Luteolin | Quercetin | Rutin | Hierochin B | Evofolin B | Balanophonin | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Physico chemical Properties | MW (g/mol) |
564.49 | 448.38 | 770.69 | 354.31 | 272.25 | 304.25 | 286.24 | 302.24 | 610.52 | 372.41 | 318.32 | 356.37 | |
HBA | 14 | 11 | 18 | 9 | 5 | 7 | 6 | 7 | 16 | 6 | 6 | 6 | ||
HBD | 10 | 8 | 10 | 6 | 3 | 5 | 4 | 5 | 10 | 2 | 3 | 2 | ||
Lipophilicity Log Po/w |
iLOGP | 1.73 | 1.27 | 2.46 | 0.96 | 1.75 | 1.30 | 1.86 | 1.63 | 1.58 | 3.36 | 2.24 | 2.79 | |
XLOGP3 | -1.64 | -0.15 | 0.12 | -0.42 | 2.52 | 0.95 | 2.53 | 1.54 | -0.33 | 2.24 | 1.78 | 2.04 | ||
MLOGP | -3.97 | -2.51 | -3.42 | -1.05 | 0.71 | -0.64 | -0.03 | -0.56 | -3.89 | 1.31 | 0.78 | 1.01 | ||
Absorption | Water solubility (Log S) |
-0.84 Soluble |
-1.79 Soluble |
-2.75 Soluble |
0.40 Soluble |
-3.42 Soluble |
-2.03 Soluble |
-3.82 Soluble |
-3.24 Soluble |
-0.29 Soluble |
-4.82 Moderate soluble |
-3.83 Soluble |
-4.25 Moderate soluble |
|
GI | Low | Low | Low | Low | High | High | High | High | Low | High | High | High | ||
Log Kp (skin permeation) cm/s |
-10.91 | -9.14 | -10.92 | -8.76 | -6.17 | -7.48 | -6.25 | -7.05 | -10.26 | -6.98 | -6.98 | -7.03 | ||
Distribution | BBB permeant |
No | No | No | No | No | No | No | No | No | Yes | No | No | |
Metabolism | CYP1A2 inhibitor | No | No | No | No | Yes | No | Yes | Yes | No | No | No | No | |
CYP2C19 inhibitor | No | No | No | No | No | No | No | No | No | No | No | No | ||
CYP2C9 inhibitor | No | No | No | No | No | No | No | No | No | No | No | No | ||
CYP2D6 inhibitor | No | No | No | No | No | No | Yes | Yes | No | Yes | No | No | ||
CYP3A4 inhibitor | No | No | No | No | Yes | No | Yes | Yes | No | No | Yes | No | ||
Drug likeness | Lipinski | No | No | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
Yes |
Metabolite Name |
Classification | |||||
---|---|---|---|---|---|---|
Organ Toxicity (%Probability) |
Toxicity Endpoint (% Probability) | |||||
Hepatotoxicity | Carcinogenicity | Immunotoxicity | Mutagenicity | Cytotoxicity | ||
Apigenin-6-C-glucoside | Inactive(0.81) | Inactive(0.69) | Inactive(0.85) | Inactive(0.55) | Inactive(0.81) | |
Luteolin-8-C-glucoside | Inactive(0.81) | Inactive(0.72) | Active(0.52) | Active(0.52) | Inactive(0.87) | |
isovitexin 7-O-[isoferuloyl]-glucoside | Inactive(0.81) | Inactive(0.88) | Active(0.99) | Inactive(0.52) | Inactive(0.65) | |
Cis-5-Caffeoyl quinic acid | Inactive(0.72) | Inactive(0.68) | Active(0.99) | Inactive(0.93) | Inactive(0.80) | |
Naringenin | Inactive(0.67) | Inactive(0.62) | Inactive(0.88) | Inactive(0.83) | Active(0.59) | |
Taxifolin | Inactive(0.69) | Active(0.68) | Inactive(0.76) | Active(0.51) | Inactive(0.99) | |
Luteolin | Inactive(0.69) | Active(0.68) | Inactive(0.97) | Active(0.51) | Inactive(0.99) | |
Quercetin | Inactive(0.69) | Active(0.68) | Inactive(0.87) | Active(0.51) | Inactive(0.99) | |
Rutin | Inactive(0.80) | Inactive(0.91) | Active(0.98) | Inactive(0.88) | Inactive(0.64) | |
Hierochin B | Inactive(0.79) | Inactive(0.59) | Active(0.90) | Inactive(0.73) | Inactive(0.91) | |
Evofolin B | Inactive(0.82) | Inactive(0.74) | Inactive(0.94) | Inactive(0.70) | Inactive(0.98) | |
Balanophonin | Inactive(0.72) | Inactive(0.58) | Active(0.95) | Inactive(0.64) | Inactive(0.89) |
Metabolite Name | Pa | Pi |
---|---|---|
Apigenin-6-C-glucoside | 0.831 | 0.004 |
Luteolin-8-C-glucoside | 0.872 | 0.003 |
Isovitexin 7-O-[isoferuloyl]-glucoside | 0.988 | 0.001 |
Cis-5-caffeoylquinic Acid | 0.846 | 0.004 |
Naringenin | 0.751 | 0.018 |
Taxifolin | 0.821 | 0.005 |
Luteolin | 0.783 | 0.014 |
Quercetin | 0.797 | 0.012 |
Rutin | 0.983 | 0.001 |
Hierochin B | 0.636 | 0.038 |
Evofolin B | 0.387 | 0.033 |
Balanophonin | 0.552 | 0.056 |
Metabolites | AR | ER α | ERβ | GR | LXR α | LXR β | MR | PPAR α | PPAR β | PPAR γ | PR | RXR α | TR α | TR β |
apigenin-6-C-glucoside | 5.7 | -7.1 | 3.1 | -10.2 | -7.9 | -9.4 | 2.1 | -6.3 | -8 | -7.6 | -2.5 | -6.2 | -5.9 | -7.6 |
luteolin-8-C-glucoside | 1.4 | -6.1 | -4.1 | -6.4 | -6.8 | -7.9 | -4.2 | -8.1 | -7.1 | -7.9 | -2.9 | -8.4 | -1.9 | -2.3 |
isovitexin 7-O-[isoferuloyl]-glucoside | 15.7 | -5.4 | 8.2 | -2.7 | -4.3 | -8.4 | 6.9 | -7.7 | -8 | -8.7 | -2.9 | 0.9 | 5.1 | 2.2 |
cis-5-caffeoyl quinic acid | -6.8 | -8.5 | -8.4 | -8.9 | -8.7 | -8.9 | -7.4 | -7.6 | -7.9 | -7.8 | -2.7 | -9.3 | -8.7 | -8.4 |
Naringenin | -8.8 | -8.9 | -8.2 | -8.6 | -8.8 | -9.4 | -9.1 | -9.1 | -8.5 | -9.2 | -2.5 | -9.5 | -9.3 | -9.6 |
Taxifolin | -9.3 | -8.3 | -7.8 | -8.7 | -9.3 | -9.4 | -9 | -7.8 | -8.6 | -9.1 | -2.7 | -8.4 | -8.6 | -9.5 |
Luteolin | -9.0 | -8.6 | -7.6 | -9.2 | -9.0 | -9.6 | -9.3 | -9.0 | -8.5 | -9.2 | -2.5 | -9.7 | -9.4 | -9.5 |
Quercetin | -8.7 | -8.3 | -7.2 | -9.5 | -9.1 | -9.2 | -9.1 | -8.0 | -8.5 | -9.2 | -2.8 | -8.6 | -8.9 | -9.1 |
Rutin | 7.6 | -5.4 | 2.0 | -5.8 | -7.5 | -7.2 | 0.8 | -7.6 | -7.8 | -7.4 | -2.8 | -5.2 | 2.3 | -4.0 |
Hierochin B | -0.6 | -5.1 | -1.4 | -8.8 | -8.7 | -9.1 | -5.1 | -7.2 | -7.8 | -7.7 | -2.3 | -6.8 | -7.5 | -8.6 |
Evofolin B | -8.0 | -7.6 | -7.8 | -7.6 | -8.3 | -8.3 | -7.9 | -7.6 | -7.2 | -7.1 | -2.7 | -8.4 | -8.3 | -8.8 |
Balanophonin | -3.1 | -5.9 | -1.8 | -8.9 | -9.1 | -9.3 | -5.5 | -7.7 | -7.8 | -7.4 | -2.3 | -8.3 | -7.2 | -9.0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Submitted:
22 May 2024
Posted:
23 May 2024
You are already at the latest version
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Submitted:
22 May 2024
Posted:
23 May 2024
You are already at the latest version
Peak No. | Rt (min) | [M+H]+ | [M―H]― | Err PPM | Molecular formula | Tentative Identification | Literature Review of the Compounds |
---|---|---|---|---|---|---|---|
Peak A (M1) | (21.445 ― 21.793) | 433.29 | 431.5 | ―0.65 | C21H20O10 | Apigenin-6-C-glucoside(isovitexin) | [23,24] |
Peak B (M2) | (36.628 ― 36.694) | 449.29 | 447.3 | ―0.50 | C21H20O11 | Luteolin-8-C-glucoside (orientin) | [23,24] |
Peak C (M3) | (32.948 ― 32.965) | 771.50 | 769.7 | ―0.45 | C37H38O18 | Isovitexin-7-O-glucoside | [23] |
Peak D (M4) | (31.058 ― 31.257) | 355.24 | 353.5 | ―0.65 | C16H18O9 | 5-Caffeoylquinic acid | [23] |
Peak E (M5) | (27.893 ― 28.125) | 273.2 | 271.3 | ―0.45 | C15H12O5 | Naringenin | [21,24–26] |
Peak F (M6) | (29.484 ― 29.650) | 305.14 | 303.3 | ―0.65 | C15H12O7 | Taxifolin | [26] |
Peak G (M7) | (25.754 ― 25.821) | 287.13 | 285.3 | ―0.40 | C15H12O6 | Luteolin | [21,26] |
Peak H (M8) | (28.804 ― 29.268) | 303.13 | 301.9 | ―0.70 | C15H10O7 | Quercetin | [23,25,26] |
Peak I (M9) | (32.020 ― 32.467) | 611.34 | 609.4 | ―0.65 | C27H30O16 | Rutin | [21,26] |
Peak J (M10) | (33.048 ― 33.765) | 373.46 | 371.37 | ―0.70 | C21H24O6 | Hierochin B | [21,26] |
Peak K (M11) | (26.142 ― 26.324) | 319.32 | 317.38 | ―0.85 | C17H18O6 | Evofolin B | [21] |
Peak L (M12) | (28.173 ― 28.397) | 357.46 | 355.39 | ―0.65 | C20H20O6 | Balanophonin | [21,26] |
Metabolite Name | Glide Docking Score | Molecular interactions |
---|---|---|
Apigenin-6-C-glucoside | -10.26 | H bonds: LEU 648 π-π : PHE 649, PHE 1013 |
Luteolin-8-C-glucoside | -8.40 | H bonds: GLU 802, LYS 771 π-π: PHE 649, PHE 1013 |
Isovitexin 7-O-[isoferuloyl]-glucoside | -4.49 | H bonds: THR 1010 π-π: PHE 649, LYS 771, PHE 914, PHE 1009, PHE 1013 |
Cis-5-caffeoylquinic acid | -10.19 | H bonds: LEU 648, THR 1010 π-π: PHE 914, PHE 1009 |
Naringenin | -9.96 | H bonds: GLU 802, THR 1010 π-π: PHE 914, PHE 1009 |
Taxifolin | -7.88 | H bonds: GLU 802 π-π: PHE 649, PHE 1013 |
Luteolin | -10.43 | H bonds: SER 876, ARG 880, THR 1010 π-π: PHE 914, PHE 1009 |
Quercetin | -11.15 | H bonds: GLU 802, SER 876, ARG 880, THR 1010 π-π: PHE 914, PHE 1009 |
Rutin | -12.39 | H bonds: GLU 802, GLU 879, SER 876, HIS 875 Pi-Pi: PHE 1013 π-cation: LYS 771 |
Hierochin B | -7.75 | π-π: PHE 1009 |
Evofolin B | -8.54 | H bonds: LYS771, SER 876 π-π: PHE 914, PHE 1009, PHE 1013 |
Balanophonin | -8.53 | H bonds: LYS 771 π-π: PHE 914, PHE 1009 |
Metabolite | Rutin | Quercetin | Luteolin | Allopurinol |
IC50 value (µM) | 11.35 ±2.09 | 11.1 ±1.72 | 21.58 ±2.41 | 4.3±1.01 |
Properties | Parameters | Apigenin-6-C-glucoside | Luteolin-8-C-glucoside | Isovitexin 7-O-[isoferuloyl]-glucoside | Cis-5-caffeoylquinic acid | Naringenin | Taxifolin | Luteolin | Quercetin | Rutin | Hierochin B | Evofolin B | Balanophonin | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Physico chemical Properties | MW (g/mol) |
564.49 | 448.38 | 770.69 | 354.31 | 272.25 | 304.25 | 286.24 | 302.24 | 610.52 | 372.41 | 318.32 | 356.37 | |
HBA | 14 | 11 | 18 | 9 | 5 | 7 | 6 | 7 | 16 | 6 | 6 | 6 | ||
HBD | 10 | 8 | 10 | 6 | 3 | 5 | 4 | 5 | 10 | 2 | 3 | 2 | ||
Lipophilicity Log Po/w |
iLOGP | 1.73 | 1.27 | 2.46 | 0.96 | 1.75 | 1.30 | 1.86 | 1.63 | 1.58 | 3.36 | 2.24 | 2.79 | |
XLOGP3 | -1.64 | -0.15 | 0.12 | -0.42 | 2.52 | 0.95 | 2.53 | 1.54 | -0.33 | 2.24 | 1.78 | 2.04 | ||
MLOGP | -3.97 | -2.51 | -3.42 | -1.05 | 0.71 | -0.64 | -0.03 | -0.56 | -3.89 | 1.31 | 0.78 | 1.01 | ||
Absorption | Water solubility (Log S) |
-0.84 Soluble |
-1.79 Soluble |
-2.75 Soluble |
0.40 Soluble |
-3.42 Soluble |
-2.03 Soluble |
-3.82 Soluble |
-3.24 Soluble |
-0.29 Soluble |
-4.82 Moderate soluble |
-3.83 Soluble |
-4.25 Moderate soluble |
|
GI | Low | Low | Low | Low | High | High | High | High | Low | High | High | High | ||
Log Kp (skin permeation) cm/s |
-10.91 | -9.14 | -10.92 | -8.76 | -6.17 | -7.48 | -6.25 | -7.05 | -10.26 | -6.98 | -6.98 | -7.03 | ||
Distribution | BBB permeant |
No | No | No | No | No | No | No | No | No | Yes | No | No | |
Metabolism | CYP1A2 inhibitor | No | No | No | No | Yes | No | Yes | Yes | No | No | No | No | |
CYP2C19 inhibitor | No | No | No | No | No | No | No | No | No | No | No | No | ||
CYP2C9 inhibitor | No | No | No | No | No | No | No | No | No | No | No | No | ||
CYP2D6 inhibitor | No | No | No | No | No | No | Yes | Yes | No | Yes | No | No | ||
CYP3A4 inhibitor | No | No | No | No | Yes | No | Yes | Yes | No | No | Yes | No | ||
Drug likeness | Lipinski | No | No | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
Yes |
Metabolite Name |
Classification | |||||
---|---|---|---|---|---|---|
Organ Toxicity (%Probability) |
Toxicity Endpoint (% Probability) | |||||
Hepatotoxicity | Carcinogenicity | Immunotoxicity | Mutagenicity | Cytotoxicity | ||
Apigenin-6-C-glucoside | Inactive(0.81) | Inactive(0.69) | Inactive(0.85) | Inactive(0.55) | Inactive(0.81) | |
Luteolin-8-C-glucoside | Inactive(0.81) | Inactive(0.72) | Active(0.52) | Active(0.52) | Inactive(0.87) | |
isovitexin 7-O-[isoferuloyl]-glucoside | Inactive(0.81) | Inactive(0.88) | Active(0.99) | Inactive(0.52) | Inactive(0.65) | |
Cis-5-Caffeoyl quinic acid | Inactive(0.72) | Inactive(0.68) | Active(0.99) | Inactive(0.93) | Inactive(0.80) | |
Naringenin | Inactive(0.67) | Inactive(0.62) | Inactive(0.88) | Inactive(0.83) | Active(0.59) | |
Taxifolin | Inactive(0.69) | Active(0.68) | Inactive(0.76) | Active(0.51) | Inactive(0.99) | |
Luteolin | Inactive(0.69) | Active(0.68) | Inactive(0.97) | Active(0.51) | Inactive(0.99) | |
Quercetin | Inactive(0.69) | Active(0.68) | Inactive(0.87) | Active(0.51) | Inactive(0.99) | |
Rutin | Inactive(0.80) | Inactive(0.91) | Active(0.98) | Inactive(0.88) | Inactive(0.64) | |
Hierochin B | Inactive(0.79) | Inactive(0.59) | Active(0.90) | Inactive(0.73) | Inactive(0.91) | |
Evofolin B | Inactive(0.82) | Inactive(0.74) | Inactive(0.94) | Inactive(0.70) | Inactive(0.98) | |
Balanophonin | Inactive(0.72) | Inactive(0.58) | Active(0.95) | Inactive(0.64) | Inactive(0.89) |
Metabolite Name | Pa | Pi |
---|---|---|
Apigenin-6-C-glucoside | 0.831 | 0.004 |
Luteolin-8-C-glucoside | 0.872 | 0.003 |
Isovitexin 7-O-[isoferuloyl]-glucoside | 0.988 | 0.001 |
Cis-5-caffeoylquinic Acid | 0.846 | 0.004 |
Naringenin | 0.751 | 0.018 |
Taxifolin | 0.821 | 0.005 |
Luteolin | 0.783 | 0.014 |
Quercetin | 0.797 | 0.012 |
Rutin | 0.983 | 0.001 |
Hierochin B | 0.636 | 0.038 |
Evofolin B | 0.387 | 0.033 |
Balanophonin | 0.552 | 0.056 |
Metabolites | AR | ER α | ERβ | GR | LXR α | LXR β | MR | PPAR α | PPAR β | PPAR γ | PR | RXR α | TR α | TR β |
apigenin-6-C-glucoside | 5.7 | -7.1 | 3.1 | -10.2 | -7.9 | -9.4 | 2.1 | -6.3 | -8 | -7.6 | -2.5 | -6.2 | -5.9 | -7.6 |
luteolin-8-C-glucoside | 1.4 | -6.1 | -4.1 | -6.4 | -6.8 | -7.9 | -4.2 | -8.1 | -7.1 | -7.9 | -2.9 | -8.4 | -1.9 | -2.3 |
isovitexin 7-O-[isoferuloyl]-glucoside | 15.7 | -5.4 | 8.2 | -2.7 | -4.3 | -8.4 | 6.9 | -7.7 | -8 | -8.7 | -2.9 | 0.9 | 5.1 | 2.2 |
cis-5-caffeoyl quinic acid | -6.8 | -8.5 | -8.4 | -8.9 | -8.7 | -8.9 | -7.4 | -7.6 | -7.9 | -7.8 | -2.7 | -9.3 | -8.7 | -8.4 |
Naringenin | -8.8 | -8.9 | -8.2 | -8.6 | -8.8 | -9.4 | -9.1 | -9.1 | -8.5 | -9.2 | -2.5 | -9.5 | -9.3 | -9.6 |
Taxifolin | -9.3 | -8.3 | -7.8 | -8.7 | -9.3 | -9.4 | -9 | -7.8 | -8.6 | -9.1 | -2.7 | -8.4 | -8.6 | -9.5 |
Luteolin | -9.0 | -8.6 | -7.6 | -9.2 | -9.0 | -9.6 | -9.3 | -9.0 | -8.5 | -9.2 | -2.5 | -9.7 | -9.4 | -9.5 |
Quercetin | -8.7 | -8.3 | -7.2 | -9.5 | -9.1 | -9.2 | -9.1 | -8.0 | -8.5 | -9.2 | -2.8 | -8.6 | -8.9 | -9.1 |
Rutin | 7.6 | -5.4 | 2.0 | -5.8 | -7.5 | -7.2 | 0.8 | -7.6 | -7.8 | -7.4 | -2.8 | -5.2 | 2.3 | -4.0 |
Hierochin B | -0.6 | -5.1 | -1.4 | -8.8 | -8.7 | -9.1 | -5.1 | -7.2 | -7.8 | -7.7 | -2.3 | -6.8 | -7.5 | -8.6 |
Evofolin B | -8.0 | -7.6 | -7.8 | -7.6 | -8.3 | -8.3 | -7.9 | -7.6 | -7.2 | -7.1 | -2.7 | -8.4 | -8.3 | -8.8 |
Balanophonin | -3.1 | -5.9 | -1.8 | -8.9 | -9.1 | -9.3 | -5.5 | -7.7 | -7.8 | -7.4 | -2.3 | -8.3 | -7.2 | -9.0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Wenduo Ji
et al.
Molecules,
2023
Md. Forid
et al.
Molecules,
2021
Elixabet Díaz-de-Cerio
et al.
IJMS,
2023
© 2024 MDPI (Basel, Switzerland) unless otherwise stated